KOE:196170

Alteogen Inc. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 12:50 UTC

Last close

n/aKRW

Market data

75.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
65.6%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
46.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

Price is the furthest below its sector's middle: 0.05 against 0.37 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

3.71x

8.85x

-23.21x

1.96x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales3.71x
Its own average over 10 years, 58.20B.
Profit8.85x
Its own average over 10 years, 16.01B.
Free cash flow-23.21x
Its own average over 10 years, -4.36B.
Debt1.96x
Its own average over 8 years, 51.49B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -23.21 times.

Sales is 3.71 times its own 10-year average; Profit is 8.85 times its own 10-year average; Free cash flow is -23.21 times its own 10-year average; Debt is 1.96 times its own 8-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average3.71
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Profit against its own 10-year average8.85
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Free cash flow against its own 10-year average-23.21
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Debt against its own 8-year average1.96
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
KRW